# Carlisle Companies Inc: Form 10-Q for the period ended Sep 30, 2021

- Company: [Carlisle Companies Inc](/companies/csl.md) (CIK 790051)
- Form: 10-Q
- Filed: 2021-10-26
- Accepted by EDGAR: Oct 26, 2021, 15:01 ET
- Period: 2021-09-30
- Accession: 0000790051-21-000233
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/790051/000079005121000233/csl-20210930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/790051/000079005121000233/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-07-01 to 2021-09-30 | $1.32bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2021-01-01 to 2021-09-30 | $3.43bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-07-01 to 2021-09-30 | $944.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2021-01-01 to 2021-09-30 | $2.51bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2021-07-01 to 2021-09-30 | $12.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2021-01-01 to 2021-09-30 | $37.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-07-01 to 2021-09-30 | $192.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2021-01-01 to 2021-09-30 | $504.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | $166.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-01-01 to 2021-09-30 | $385.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-07-01 to 2021-09-30 | $19.8m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2021-01-01 to 2021-09-30 | $58.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-07-01 to 2021-09-30 | $33.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2021-01-01 to 2021-09-30 | $66.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | $142.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-01-01 to 2021-09-30 | $293.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-07-01 to 2021-09-30 | $2.67 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2021-01-01 to 2021-09-30 | $5.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-07-01 to 2021-09-30 | $2.70 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2021-01-01 to 2021-09-30 | $5.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-07-01 to 2021-09-30 | 53,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2021-01-01 to 2021-09-30 | 53,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2021-01-01 to 2021-09-30 | $283.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-01-01 to 2021-09-30 | $88.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2021-01-01 to 2021-09-30 | $84.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2021-01-01 to 2021-09-30 | $290.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2021-09-30 | $2.08bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-09-30 | $7.07bn | us-gaap:Assets |
| Current liabilities | at 2021-09-30 | $851.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-09-30 | $2.92bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-09-30 | $2.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-09-30 | $2.54bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 50,355 characters.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a leading supplier of innovative building envelope products and energy-efficient solutions for customers creating sustainable buildings of the future. Through its Carlisle Construction Materials ("CCM") business and family of leading brands, Carlisle delivers innovative, labor-reducing and environmentally responsible products and solutions to customers across the planet through the Carlisle Experience. Over the life of a building, Carlisle’s products help drive lower greenhouse gas emissions, improve energy savings for building owners and operators, and increase a building’s resiliency to the elements. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle also is a leading provider of products to the aerospace, medical technologies and general industrial markets through its Carlisle Interconnect Technologies ("CIT") and Carlisle Fluid Technologies ("CFT") business segments. Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

### Executive Overview

As we exited the third quarter, the impact of the COVID-19 pandemic appears to be past its summer and early autumn peak. This trend, combined with improvements in our supply chain and positive movement towards a resumption of passenger air travel approaching pre-pandemic levels, is driving increased optimism about our ability to deliver continued strong results. We have also seen strong demand in our building products markets. Along with steadily growing backlog across all three of Carlisle's segments, we are increasingly positive entering the fourth quarter and 2022. Nonetheless, within the third quarter of 2021, our teams faced a very challenging operating environment given difficult supply chain and labor conditions, as well as the impact of Hurricane Ida. Despite these challenges, we believe Carlisle's employees again displayed their resilience in delivering record results, all the while doing so with strict adherence to the same health and safety protocols and precautions that have been in place throughout the pandemic, extending Carlisle's excellent safety record.

Vision 2025 continues to provide clarity of mission and a consistent direction for our entire organization. We have stayed the course and maintain confidence in our ability to execute on our strategies, despite the challenges throughout the COVID-19 pandemic. Vision 2025 focuses our continuous improvement culture on providing our customers with innovative products of the best quality at the right place, at the right time. Ensuring the highest level of communication, transparency and service is embodied in what we call the Carlisle Experience, which we are committed to delivering to all our channel partners.

As introduced in Vision 2025, we committed to a leaner, more focused portfolio and a pivot towards investing in our highest-returning businesses, particularly CCM. This commitment was further evidenced in the third quarter by our divestiture of Carlisle Brake & Friction ("CBF"), which CCM's outstanding performance affirmed that our conviction is correct. CCM's best-in-class team delivered record third quarter revenues in an extremely difficult operating environment. Our increasing focus on building products is exemplified by our recent acquisition of ASP Henry Holdings, Inc. ("Henry"), which delivered excellent results in its first month with Carlisle, and where integration thus far has been smooth.

While we're pleased with CCM's performance, CIT and CFT both contributed to our results and exhibited continued progress. As we expected, CIT returned to growth in the third quarter. CIT's commercial aerospace backlog has consistently grown in 2021, and has now surpassed second quarter of 2020 levels, a significant milestone. Coupling this with the improving backlog in our medical technologies business, we expect recovery to continue at CIT, with solid leverage on this growth over the coming quarters and years. Driven by accelerating industrial capital expenditures as companies expand capacity in response to supply constraints, CFT delivered strong revenue growth, despite the many documented supply chain issues challenging the automotive industry.

We remain balanced in our approach to capital deployment. We increased our dividend for the 45th consecutive year, returning $84.2 million during the first nine months in the form of dividends. While closing on the acquisition of Henry, the largest acquisition in Carlisle's history, we also repurchased $290.6 million of shares during the first nine months. Finally, we had a successful debt issuance of $850 million of senior notes at a weighted average rate of 1.6%, which lowered Carlisle's cost of debt and extended its weighted-average maturity.

With all of our businesses trending positively, and leveraging the clarity of mission that Vision 2025 provides us, Carlisle is well positioned for continued acceleration through the recovery and beyond.

#### Summary of Financial Results

*(in millions, except per share amounts)*

|  | Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $1,315.6 | $1,057.0 | $3,434.3 | $2,981.6 |
| Operating income | $166.5 | $154.8 | $385.0 | $376.5 |
| Operating margin percentage | 12.7% | 14.6% | 11.2% | 12.6% |
| Income from continuing operations | $113.0 | $102.7 | $256.2 | $243.5 |
| Income (loss) from discontinued operations | $29.1 | $(0.4) | $37.4 | $(4.0) |
| Diluted earnings per share attributable to common shares: |  |  |  |  |
| Income from continuing operations | $2.12 | $1.88 | $4.80 | $4.38 |
| Income (loss) from discontinued operations | $0.55 | $(0.01) | $0.70 | $(0.07) |
| Non-comparable items(1) | $27.1 | $5.7 | $44.0 | $33.1 |

(1) Non-comparable items include items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

Revenues increased in the third quarter and first nine months of 2021 primarily reflecting higher volumes and price realization in our CCM and CFT segments, contributions from the acquisition of Henry in the CCM segment and favorable foreign currency impacts, partially offset by lower volumes in our CIT segment in the nine-month period, which has been impacted by the prolonged aerospace decline.

The decrease in operating margin percentage in the third quarter and first nine months of 2021 primarily reflected raw material and wage inflation across all segments. The decrease in operating income was partially offset by price realization, higher volumes and savings from the Carlisle Operating System ("COS").

Diluted earnings per share from continuing operations increased primarily due to improved operating income performance ($0.16 per share in the third quarter of 2021 and $0.12 per share in the first nine months of 2021), a lower effective tax rate ($0.03 per share in the third quarter of 2021 and $0.15 per share in the first nine months of 2021), and reduced average shares outstanding ($0.06 per share in the third quarter of 2021 and $0.19 per share in the first nine months of 2021) resulting from purchases under our share repurchase program.

We generated $283.9 million in operating cash flow in the first nine months of 2021, and utilized cash on hand and cash provided by operations to return capital to shareholders through dividends and share repurchases, and to fund capital expenditures.

### Consolidated Results of Operations

### Revenues

*(in millions)*

|  | 2021 | 2020 | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Three months ended September 30 | $1,315.6 | $1,057.0 | $258.6 | 24.5% | 4.8% | 19.4% | 0.3% |
| Nine months ended September 30 | $3,434.3 | $2,981.6 | $452.7 | 15.2% | 2.0% | 12.6% | 0.6% |

Revenues increased in the third quarter and first nine months of 2021 primarily reflecting higher sales volumes and price realization in our CCM and CFT segments across all markets in which they operate, contributions from the acquisition of Henry in the CCM segment and favorable foreign currency impacts, partially offset by lower CIT volumes in the nine-month period as a result of the prolonged aerospace decline.

### Gross Margin

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross margin | $371.6 | $317.9 | $53.7 | 16.9% | $924.2 | $857.4 | $66.8 | 7.8% |
| Gross margin percentage | 28.2% | 30.1% |  |  | 26.9% | 28.8% |  |  |
| Depreciation and amortization | $26.4 | $26.0 |  |  | $75.1 | $79.0 |  |  |

Gross margin percentage (gross margin expressed as a percentage of revenues) declined in the third quarter and first nine months of 2021, driven by raw material and wage inflation, partially offset by savings from COS. Cost of goods sold for the third quarter and first nine months of 2021 included $5.0 million of acquired inventory costs associated with the Henry acquisition in the CCM segment. Also included in cost of goods sold were exit and disposal costs totaling $2.7 million for the third quarter and $7.1 million in the first nine months of 2021, primarily at CIT attributable to our restructuring initiatives, compared with $3.7 million for the third quarter and $9.4 million for the first nine months of 2020. Refer to Note 8 for further information on exit and disposal activities.

### Selling and Administrative Expenses

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling and administrative expenses | $192.6 | $153.0 | $39.6 | 25.9% | $504.7 | $448.5 | $56.2 | 12.5% |
| As a percentage of revenues | 14.6% | 14.5% |  |  | 14.7% | 15.0% |  |  |
| Depreciation and amortization | $30.7 | $24.3 |  |  | $79.9 | $72.2 |  |  |

The increase in selling and administrative expenses in the third quarter and first nine months of 2021 primarily reflected acquisition costs of $17.3 million related to Henry in the CCM segment, higher incentive compensation costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $0.9 million for the third quarter and $4.3 million for the first nine months of 2021, primarily at CIT attributable to our restructuring initiatives, compared with $1.2 million for the third quarter and $4.0 million for the first nine months of 2020. Refer to Note 8 for further information on exit and disposal activities.

### Research and Development Expenses

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development expenses | $12.8 | $11.5 | $1.3 | 11.3% | $37.0 | $35.1 | $1.9 | 5.4% |
| As a percentage of revenues | 1.0% | 1.1% |  |  | 1.1% | 1.2% |  |  |
| Depreciation and amortization | $0.5 | $0.5 |  |  | $1.4 | $1.5 |  |  |

Research and development expenses were higher in the third quarter and first nine months of 2021, compared with the 2020 periods, primarily reflecting higher new product development expenses at our CIT and CFT segments.

### Other Operating Income, net

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Other operating income, net | $(0.3) | $(1.4) | $1.1 | (78.6)% | $(2.5) | $(2.7) | $0.2 | (7.4)% |

Other operating income, net in the 2021 periods primarily reflected rebates ($0.9 million in third quarter and $2.6 million in the first nine months) and royalty income ($0.4 million in third quarter and $1.1 million in the first nine months), partially offset by intangible asset impairments of $1.8 million in both the third quarter and first nine months at CIT.

Other operating income, net in the 2020 periods primarily reflected rebates ($0.9 million in third quarter and $2.1 million in the first nine months), rental income ($1.1 million in the first nine months) and royalty income ($0.3 million in third quarter and $1.0 million in the first nine months), partially offset by losses on sale of assets ($0.5 million in third quarter and $2.0 million in the first nine months), primarily at CCM and CIT.

### Operating Income

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $166.5 | $154.8 | $11.7 | 7.6% | $385.0 | $376.5 | $8.5 | 2.3% |
| Operating margin percentage | 12.7% | 14.6% |  |  | 11.2% | 12.6% |  |  |

Refer to *Segment Results of Operations* within this MD&A for further information related to segment operating income results.

### Interest Expense, net

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense, net | $19.8 | $19.1 | $0.7 | 3.7% | $58.2 | $57.8 | $0.4 | 0.7% |

Interest expense, net of capitalized interest, increased in the third quarter and first nine months of 2021 primarily reflecting draws on our revolving credit facility in the third quarter of 2021, which were repaid in the third quarter of 2021. Refer to Note 12 for further information on our long-term debt.

### Loss on Extinguishment of Debt

Loss on extinguishment of debt of $8.8 million in the first nine months of 2020 related to the early redemption in full of $250.0 million aggregate principal amount of our outstanding 5.125% unsecured senior notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 at the redemption price of $262.1 million. The redemption price included a premium of $8.4 million, along with $0.4 million of deferred issuance costs.

### Interest Income

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest income | $(0.2) | $(0.7) | $0.5 | (71.4)% | $(1.1) | $(4.0) | $2.9 | (72.5)% |

Interest income decreased during the third quarter and first nine months of 2021 primarily reflecting lower cash balances and lower yields.

### Other Non-operating Expense (Income), net

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| Other non-operating expense (income), net | $0.9 | $0.5 | $0.4 | NM | $5.6 | $(0.4) | $6.0 | NM |

Other non-operating expense (income), net in the first nine months of 2021 primarily reflected the release of a portion of the indemnification asset related to the Petersen Aluminum Corporation ("Petersen") acquisition resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

Other non-operating expense (income), net, in the first nine months of 2020 primarily reflected foreign exchange gains from the strengthening of the U.S. Dollar, partially offset by the release of a portion of the indemnification asset related to the Petersen acquisition resulting from escrow expirations.

### Income Taxes

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Provision for income taxes | $33.0 | $33.2 | $(0.2) | (0.6)% | $66.1 | $70.8 | $(4.7) | (6.6)% |
| Effective tax rate | 22.6% | 24.4% |  |  | 20.5% | 22.5% |  |  |

The effective income tax rate on continuing operations for the first nine months of 2021 was 20.5%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 24.2% and a tax impact of $12.1 million related to discrete activity. The year-to-date net discrete tax benefit relates primarily to a reduction of prior year tax liabilities and excess tax benefits related to stock compensation.

The effective income tax rate on continuing operations for the first nine months of 2020 was 22.5%.

### Income (Loss) from Discontinued Operations

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% | 2021 | Nine Months Ended September 30, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| Income (loss) from discontinued operations before income taxes | $2.2 | $0.5 | $1.7 | NM | $13.0 | $(4.7) | $17.7 | NM |
| (Benefit from) provision for income taxes | (26.9) | 0.9 |  |  | (24.4) | (0.7) |  |  |
| Income (loss) from discontinued operations | $29.1 | $(0.4) |  |  | $37.4 | $(4.0) |  |  |

Income (loss) from discontinued operations for the third quarter and first nine months of 2021 reflects improved operating results from the CBF segment, compared with the 2020 periods. The 2021 periods also reflect a pre-tax loss on sale, offset by an income tax benefit from the sale transaction.

### Segment Results of Operations

### Carlisle Construction Materials

CCM's best-in-class team delivered record third quarter revenues in an extremely difficult operating environment. In anticipation of solid construction market demand in 2021, we ensured our employees stood ready to produce; communicated clearly with our channel partners about our raw material requirements; built inventory; increased capacity; and remained steadfast in applying COS to drive efficiencies across CCM. We intend to maintain our pricing discipline in the marketplace, capturing the full value of the Carlisle Experience, which reflects our unyielding commitment to servicing the increasingly complex needs of our customers.

CCM continues to benefit from a growing backlog fueled by the strong re-roofing cycle in the United States, an ever-increasing emphasis on the energy-efficiency of buildings, and our investments in expansion of our presence in the building envelope. Our increasing focus on building products is exemplified by our recent acquisition of Henry, which delivered excellent results in its first month with Carlisle, and where integration thus far has been smooth.

Additionally, re-roofing demand remains strong in the United States market. Near term, the lingering effects of the COVID-19 pandemic and raw material and labor constraints have contributed to growing backlogs and significant increases in near term demand. With buildings accounting for a significant portion of annual global greenhouse gas emissions, we continue to focus on innovation, emphasizing the development of products that ensure greater energy efficiency.

Our drive to increase the content of energy-efficient products in our portfolio and further expand into the building envelope resulted in the purchase of Henry for $1.575 billion in cash, subject to working capital and other customary post-closing adjustments, in the third quarter. As one example of our expanded portfolio of energy-efficient products, Henry's air and vapor barriers prevent uncontrolled air leakage and can yield notable savings on heating and cooling costs. Refer to Note 3 for further information on this acquisition.

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $1,065.8 | $823.5 | $242.3 | 29.4% | 6.0% | 23.3% | 0.1% |
| Operating income | $187.1 | $181.3 | $5.8 | 3.2% |  |  |  |
| Operating margin percentage | 17.6% | 22.0% |  |  |  |  |  |
| Depreciation and amortization | $31.4 | $24.4 |  |  |  |  |  |
| Non-comparable items(1) | $22.4 | $0.8 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the third quarter of 2021 primarily reflecting price realization, higher volumes from strength in U.S. commercial roofing demand and contributions from the Henry acquisition.

CCM’s operating margin percentage decrease in the third quarter of 2021 primarily reflected raw material and wage inflation and acquisition costs, partially offset by price realization, higher volumes and savings from COS.

*(in millions)*

| 2021 | Nine Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $2,722.4 | $2,234.8 | $487.6 | 21.8% | 2.2% | 19.1% | 0.5% |
| Operating income | $485.8 | $426.6 | $59.2 | 13.9% |  |  |  |
| Operating margin percentage | 17.8% | 19.1% |  |  |  |  |  |
| Depreciation and amortization | $78.3 | $74.2 |  |  |  |  |  |
| Non-comparable items (1) | $25.1 | $3.6 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the first nine months of 2021 primarily reflecting higher volumes from strength in U.S. commercial roofing demand, price realization and contributions from the Henry acquisition.

CCM’s operating margin percentage decrease in the first nine months of 2021 primarily reflected raw material and wage inflation and acquisition costs, partially offset by price realization, higher volumes and savings from COS.

### Carlisle Interconnect Technologies

As we expected, CIT returned to growth in the third quarter. Notably, CIT is now leveraging growth quite well, with expectations for continued profitability improvement going forward. Lower demand for commercial aircraft due to the COVID-19 pandemic forced the team to focus on improving and repositioning the business for the future. CIT took significant actions, including rightsizing its footprint, and created a more efficient operating structure. CIT's commercial aerospace backlog has consistently grown in 2021, and has now surpassed second quarter of 2020 levels, a significant milestone. Coupling this with the improving backlog in our medical technologies business, we expect recovery to continue at CIT, with solid leverage on this growth over the coming quarters and years.

During the third quarter of 2021, we announced the closure of our manufacturing operations in Carlsbad, California, and the relocation of those operations to our existing facilities in North America. The project is estimated to take a remaining 13 to 17 months to complete. Total projected costs are expected to approximate $5.7 million, with approximately $4.8 million costs remaining to be incurred.

In 2020, as a result of the market declines caused by the effects of the COVID-19 pandemic, we announced the closure of our manufacturing operations in Kent, Washington, and the relocation of selected operations to our existing facilities primarily in North America. The project is estimated to be substantially complete by December 31, 2021. Total project costs are expected to approximate $17.4 million, with approximately $1.6 million remaining to be incurred.

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $178.7 | $168.5 | $10.2 | 6.1% | 0.5% | 5.2% | 0.4% |
| Operating loss | $(0.5) | $(3.7) | $3.2 | 86.5% |  |  |  |
| Operating margin percentage | (0.3)% | (2.2)% |  |  |  |  |  |
| Depreciation and amortization | $18.9 | $19.6 |  |  |  |  |  |
| Non-comparable items(1) | $4.7 | $4.8 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenues improved in the third quarter of 2021 primarily reflecting higher volumes, indicating the beginning of a recovery in the commercial aerospace market.

CIT’s operating margin percentage improved in the third quarter of 2021 driven by higher volumes, savings from COS and lower travel and other administrative costs, partially offset by raw material and wage inflation.

*(in millions)*

| 2021 | Nine Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $503.4 | $577.0 | $(73.6) | (12.8)% | 0.8% | (13.9)% | 0.3% |
| Operating (loss) income | $(24.1) | $11.2 | $(35.3) | (315.2)% |  |  |  |
| Operating margin percentage | (4.8)% | 1.9% |  |  |  |  |  |
| Depreciation and amortization | $56.5 | $58.4 |  |  |  |  |  |
| Non-comparable items(1) | $15.2 | $13.2 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenue decline in the first nine months of 2021 primarily reflected lower volumes, led by the downturn in the commercial aerospace market as a result of slow recovery in build rates on narrow and wide body aircraft by OEMs given declines in airline travel in the first half of the year.

CIT’s operating margin percentage decreased in the first nine months of 2021, driven by lower volumes, unfavorable mix, and raw material and wage inflation, partially offset by savings from COS and lower travel and other administrative costs.

### Carlisle Fluid Technologies

Driven by accelerating industrial capital expenditures as companies expand capacity in response to supply constraints, CFT delivered strong revenue growth, despite the many documented supply chain issues challenging the automotive industry. This growth was supported by a commitment to new product introductions, price discipline and excellent performance by our teams in Europe and China. We also continue to make progress integrating and growing our newer platforms of sealants and adhesives, foam and powder. With a focus on innovation, leaner cost structure, and push into automation, we are optimistic about the CFT team's ability to generate sustainable value creation by driving and leveraging solid growth at healthy incremental margins, and, ultimately delivering on its Vision 2025 goals.

*(in millions)*

| 2021 | Three Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $71.1 | $65.0 | $6.1 | 9.4% | 0.9% | 6.3% | 2.2% |
| Operating income | $4.7 | $4.4 | $0.3 | 6.8% |  |  |  |
| Operating margin percentage | 6.6% | 6.8% |  |  |  |  |  |
| Depreciation and amortization | $5.8 | $5.8 |  |  |  |  |  |
| Non-comparable items(1) | $0.2 | $0.1 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the third quarter of 2021 reflecting increased volumes, particularly in the transportation end market, price realization and favorable foreign currency impacts.

CFT’s operating margin percentage declined in the third quarter of 2021 reflecting higher wage and incentive compensation costs, partially offset by price realization and higher volumes.

*(in millions)*

| 2021 | Nine Months Ended September 30, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $208.5 | $169.8 | $38.7 | 22.8% | 2.8% | 16.3% | 3.7% |
| Operating income | $15.6 | $2.0 | $13.6 | 680.0% |  |  |  |
| Operating margin percentage | 7.5% | 1.2% |  |  |  |  |  |
| Depreciation and amortization | $17.3 | $17.4 |  |  |  |  |  |
| Non-comparable items(1) | $0.9 | $2.4 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the first nine months of 2021 reflecting increased volumes, particularly in the transportation end market, favorable foreign currency impacts, price realization and contributions from acquisitions.

CFT’s operating margin percentage performance improved for the first nine months of 2021, reflecting higher volumes, price realization and savings from COS, partially offset by higher wage and incentive compensation costs, and raw material inflation.

### Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

*(in millions)*

|  | September 30, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Europe | $23.0 | $113.7 |
| North America (excluding U.S.) | 20.1 | 50.8 |
| China | 14.9 | 18.4 |
| Asia Pacific (excluding China) | 11.1 | 27.0 |
| International cash and cash equivalents | 69.1 | 209.9 |
| U.S. cash and cash equivalents | 226.5 | 687.2 |
| Total cash and cash equivalents | $295.6 | $897.1 |

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under our Facility. In the near term, cash on hand is our primary source of liquidity. The decrease in cash and cash equivalents compared to December 31, 2020, is primarily related to the acquisition of Henry, share repurchases, payment of dividends to shareholders and capital expenditures, partially offset by a portion of the proceeds from our public offering of $300.0 million in aggregate principal amount of unsecured senior notes due in September 2023 and $550.0 million in aggregate principal amount of unsecured senior notes due in March 2032, and the sale of CBF.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in China, we may be subject to withholding taxes, and as such we have accrued $2.6 million in anticipation of those taxes as of September 30, 2021.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, as well as available liquidity under the Facility, to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets to repay the outstanding balance. Refer to *Debt Instruments* below.

### Sources and Uses of Cash and Cash Equivalents

*(in millions)*

|  | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $283.9 | $440.2 |
| Net cash used in investing activities | (1,423.2) | (106.7) |
| Net cash provided by financing activities | 533.9 | 36.7 |
| Effect of foreign currency exchange rate changes on cash | (1.2) | (2.4) |
| Change in cash and cash equivalents | $(606.6) | $367.8 |

#### Operating Activities

We generated operating cash flows of $283.9 million for the first nine months of 2021 (including working capital uses of $208.2 million), compared with $440.2 million for the first nine months of 2020 (including working capital uses of $26.5 million). Lower operating cash flows in the first nine months of 2021 primarily reflected an increase in receivables from higher sales, partially offset by higher payables due to rising raw material costs.

#### Investing Activities

Cash used in investing activities of $1,423.2 million for the first nine months of 2021 primarily reflected the acquisition of Henry for $1,573.9 million, net of cash acquired, capital expenditures of $88.9 million and investment in securities of $10.2 million, partially offset by proceeds from the sale of CBF of $247.7 million, net of cash disposed. Cash used in investing activities of $106.7 million for the first nine months of 2020 primarily reflected capital expenditures of $72.7 million.

#### Financing Activities

Cash used in financing activities of $533.9 million in the first nine months of 2021 primarily reflected net proceeds from our September offering of $850.0 million in aggregate principal amount of unsecured senior notes, partially offset by share repurchases of $290.6 million and cash dividend payments of $84.2 million, reflecting the increased quarterly dividend of $0.54 per share. Cash provided by financing activities of $36.7 million during the first nine months of 2020 primarily reflected net proceeds from our February 2020 offering of $750.0 million in aggregate principal amount of unsecured senior notes, partially offset by the early redemption of our 2020 Notes and financing costs associated with our February notes offering. Additionally during the first nine months of 2020 we used cash of $341.7 million for share repurchases and $84.5 million for dividend payments.

### Debt Instruments

#### Senior Notes

On September 28, 2021, the Company completed a public offering of $550.0 million in aggregate principal amount of unsecured senior notes with a stated interest rate of 2.20% due March 1, 2032 (the “2032 Notes”). The 2032 Notes were issued at a discount of $4.8 million, resulting in proceeds to the Company of $545.2 million. The Company incurred costs to issue the 2032 Notes of approximately $1.1 million, inclusive of credit rating agencies’ and attorneys’ fees and other costs. The discount and issuance costs are amortized to interest expense over the life of the 2032 Notes. Interest is paid each March 1 and September 1, commencing March 1, 2022.

On September 28, 2021, the Company completed a public offering of $300.0 million in aggregate principal amount of unsecured senior notes with a stated interest rate of 0.55% due September 1, 2023 (the “2023 Notes” and together with the 2032 Notes the "Notes") and callable beginning on September 1, 2022. The 2023 Notes were issued at a discount of $2.6 million, resulting in proceeds to the Company of $297.4 million. The Company incurred costs to issue the 2023 Notes of approximately $0.6 million, inclusive of credit rating agencies’ and attorneys’ fees and other costs. The discount and issuance costs are amortized to interest expense over the life of the 2023 Notes. Interest is paid each March 1 and September 1, commencing March 1, 2022.

#### Revolving Credit Facility

On September 14, 2021, the Company entered into a first amendment (the "Amendment") to the Company's Fourth Amended and Restated Credit Agreement (as amended, the "Facility") administered by JPMorgan Chase Bank, N.A. Among other things, the Amendment revised the referenced benchmark interest rates to provide for a successor interest rate to LIBOR due to the cessation of certain LIBOR rates as of December 31, 2021.

During the first nine months of 2021, borrowings and repayments under the Facility totaled $650.0 million with a weighted average interest rate of 1.125%. During the first nine months of 2020, borrowings and repayments under the Facility totaled $500.0 million with a weighted average interest rate of 1.9%. As of September 30, 2021 and December 31, 2020, the Facility had no outstanding balance and $1.0 billion available for use.

#### Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of September 30, 2021 and December 31, 2020.

Refer to Note 12 for further information on our debt instruments.

### Non-GAAP Financial Measures

### EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before income, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies. This information differs from net income and operating income determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and should not be considered in isolation or as a substitute for measures of performance determined in accordance with U.S. GAAP. The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

*(in millions)*

|  | Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Net income (GAAP) | $142.1 | $102.3 | $293.6 | $239.5 |
| Less: income (loss) from discontinued operations (GAAP) | 29.1 | (0.4) | 37.4 | (4.0) |
| Income from continuing operations (GAAP) | 113.0 | 102.7 | 256.2 | 243.5 |
| Provision for income taxes | 33.0 | 33.2 | 66.1 | 70.8 |
| Interest expense, net | 19.8 | 19.1 | 58.2 | 57.8 |
| Interest income | (0.2) | (0.7) | (1.1) | (4.0) |
| EBIT | 165.6 | 154.3 | 379.4 | 368.1 |
| Exit and disposal, and facility rationalization costs | 3.4 | 5.2 | 14.0 | 16.0 |
| Inventory step-up amortization and acquisition costs | 22.2 | 0.5 | 24.4 | 6.1 |
| Impairment charges | 1.8 | — | 1.8 | — |
| Losses (gains) from acquisitions and disposals | — | — | 3.5 | 2.2 |
| Losses (gains) from insurance | (0.3) | — | 0.2 | — |
| Losses (gains) from litigation | — | — | 0.1 | — |
| Losses on extinguishment of debt | — | — | — | 8.8 |
| Total non-comparable items | 27.1 | 5.7 | 44.0 | 33.1 |
| Adjusted EBIT | 192.7 | 160.0 | 423.4 | 401.2 |
| Depreciation | 21.6 | 20.4 | 62.2 | 61.8 |
| Amortization | 36.0 | 30.4 | 94.2 | 90.9 |
| Adjusted EBITDA | $250.3 | $210.8 | $579.8 | $553.9 |
| Divided by: |  |  |  |  |
| Total revenues | $1,315.6 | $1,057.0 | $3,434.3 | $2,981.6 |
| Adjusted EBITDA margin | 19.0% | 19.9% | 16.9% | 18.6% |

34

*(in millions)*

|  | Three Months Ended September 30, 2021 CCM | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $187.1 | $(0.5) | $4.7 | $(24.8) |
| Non-operating expense (income)(1) | 0.4 | (0.1) | (0.2) | 0.8 |
| EBIT | 186.7 | (0.4) | 4.9 | (25.6) |
| Exit and disposal, and facility rationalization costs | 0.1 | 2.8 | 0.5 | — |
| Inventory step-up amortization and acquisition costs | 22.3 | — | — | (0.1) |
| Impairment charges | — | 1.8 | — | — |
| Losses (gains) from acquisitions and disposals | — | — | — | — |
| Losses (gains) from insurance | — | — | (0.3) | — |
| Losses (gains) from litigation | — | 0.1 | — | (0.1) |
| Losses on extinguishment of debt | — | — | — | — |
| Total non-comparable items | 22.4 | 4.7 | 0.2 | (0.2) |
| Adjusted EBIT | 209.1 | 4.3 | 5.1 | (25.8) |
| Depreciation | 12.9 | 6.3 | 1.4 | 1.0 |
| Amortization | 18.5 | 12.6 | 4.4 | 0.5 |
| Adjusted EBITDA | $240.5 | $23.2 | $10.9 | $(24.3) |
| Divided by: |  |  |  |  |
| Total revenues | $1,065.8 | $178.7 | $71.1 | $— |
| Adjusted EBITDA margin | 22.6% | 13.0% | 15.3% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

*(in millions)*

|  | Three Months Ended September 30, 2020 CCM | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $181.3 | $(3.7) | $4.4 | $(27.2) |
| Non-operating expense (income)(1) | 0.3 | 0.2 | 0.1 | (0.1) |
| EBIT | 181.0 | (3.9) | 4.3 | (27.1) |
| Exit and disposal, and facility rationalization costs | 0.6 | 4.6 | — | — |
| Inventory step-up amortization and acquisition costs | 0.2 | 0.2 | 0.1 | — |
| Impairment charges | — | — | — | — |
| Losses (gains) from acquisitions and disposals | — | — | — | — |
| Losses (gains) from insurance | — | — | — | — |
| Losses (gains) from litigation | — | — | — | — |
| Losses on extinguishment of debt | — | — | — | — |
| Total non-comparable items | 0.8 | 4.8 | 0.1 | — |
| Adjusted EBIT | 181.8 | 0.9 | 4.4 | (27.1) |
| Depreciation | 11.8 | 6.3 | 1.4 | 0.9 |
| Amortization | 12.6 | 13.3 | 4.4 | 0.1 |
| Adjusted EBITDA | $206.2 | $20.5 | $10.2 | $(26.1) |
| Divided by: |  |  |  |  |
| Total revenues | $823.5 | $168.5 | $65.0 | $— |
| Adjusted EBITDA margin | 25.0% | 12.2% | 15.7% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

*(in millions)*

|  | Nine Months Ended September 30, 2021 CCM | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $485.8 | $(24.1) | $15.6 | $(92.3) |
| Non-operating expense(1) | 2.7 | (0.1) | 1.3 | 1.7 |
| EBIT | 483.1 | (24.0) | 14.3 | (94.0) |
| Exit and disposal, and facility rationalization costs | 0.1 | 13.0 | 0.9 | — |
| Inventory step-up amortization and acquisition costs | 22.3 | — | 0.1 | 2.0 |
| Impairment charges | — | 1.8 | — | — |
| Losses (gains) from acquisitions and disposals | 2.2 | 0.3 | 0.2 | 0.8 |
| Losses (gains) from insurance | 0.5 | — | (0.3) | — |
| Losses (gains) from litigation | — | 0.1 | — | — |
| Losses on extinguishment of debt | — | — | — | — |
| Total non-comparable items | 25.1 | 15.2 | 0.9 | 2.8 |
| Adjusted EBIT | 508.2 | (8.8) | 15.2 | (91.2) |
| Depreciation | 36.8 | 18.6 | 4.0 | 2.8 |
| Amortization | 41.5 | 37.9 | 13.3 | 1.5 |
| Adjusted EBITDA | $586.5 | $47.7 | $32.5 | $(86.9) |
| Divided by: |  |  |  |  |
| Total revenues | $2,722.4 | $503.4 | $208.5 | $— |
| Adjusted EBITDA margin | 21.5% | 9.5% | 15.6% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

*(in millions)*

|  | Nine Months Ended September 30, 2020 CCM | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $426.6 | $11.2 | $2.0 | $(63.3) |
| Non-operating expense (income)(1) | 3.2 | (0.4) | (3.2) | 8.8 |
| EBIT | 423.4 | 11.6 | 5.2 | (72.1) |
| Exit and disposal, and facility rationalization costs | 0.9 | 13.0 | 2.1 | — |
| Inventory step-up amortization and acquisition costs | 0.4 | 0.2 | 0.3 | 5.2 |
| Impairment charges | — | — | — | — |
| Losses (gains) from acquisitions and disposals | 2.3 | — | — | (0.1) |
| Losses (gains) from insurance | — | — | — | — |
| Losses (gains) from litigation | — | — | — | — |
| Losses on extinguishment of debt | — | — | — | 8.8 |
| Total non-comparable items | 3.6 | 13.2 | 2.4 | 13.9 |
| Adjusted EBIT | 427.0 | 24.8 | 7.6 | (58.2) |
| Depreciation | 36.5 | 18.9 | 4.0 | 2.4 |
| Amortization | 37.7 | 39.5 | 13.4 | 0.3 |
| Adjusted EBITDA | $501.2 | $83.2 | $25.0 | $(55.5) |
| Divided by: |  |  |  |  |
| Total revenues | $2,234.8 | $577.0 | $169.8 | $— |
| Adjusted EBITDA margin | 22.4% | 14.4% | 14.7% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

### Outlook

Our expectations for segment and total revenues for 2021, compared to 2020 follow:

|  | 2021 Revenue | Primary Drivers |
| --- | --- | --- |
| Carlisle Construction Materials | Mid-20% growth | •Strong re-roofing demand •Increasing demand for energy-efficient building products •Proactive pricing measures gaining traction |
| Carlisle Interconnect Technologies | Mid-single digit decline | •Commercial aerospace backlog surpassed 2Q20 levels |
| Carlisle Fluid Technologies | Mid-teens growth | •Focus on new product introductions and price realization •Markets strengthening |
| Total Carlisle | High-teens growth |  |

For the year 2021, we expect:

- Corporate expenses of approximately $120 million to $122 million;
- Depreciation and amortization expense of approximately $230 million;
- Capital expenditures of approximately $125 million;
- Interest expense, net of interest income, of approximately $82 million; and
- Base tax rate of approximately 25%.

### Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of the COVID-19 pandemic on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions; our successful completion of strategic dispositions; the cyclical nature of our businesses; the impact of information technology, cybersecurity or data security breaches at our businesses or third parties; and the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission ("SEC") from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

## Market risk

As filed, 275 characters.

There have been no material changes in the Company’s market risk for the nine months ended September 30, 2021. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2020 Annual Report on Form 10-K.

## Controls and procedures

As filed, 864 characters.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of September 30, 2021, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During the first nine months of 2021, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 149 characters.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2020 Annual Report on Form 10-K.

Filed Oct 26, 2021.
Source: SEC EDGAR, the filing index for accession 0000790051-21-000233. Last ingested by Listed: Nov 10, 2026, 16:42 ET. No prices; not investment advice.
